Blood Transfusion Error Lawsuits: Proving Negligence in NY

When Blood Transfusions Cause Harm

Blood transfusions are used to replace blood lost due to surgery, trauma, bleeding disorders, or anemia — and to treat conditions like sickle cell disease, leukemia, and chemotherapy-induced anemia. While transfusions are generally safe when performed correctly, errors can cause catastrophic harm:

- ABO-incompatible transfusions: Transfusing the wrong blood type — causing a severe, potentially fatal immune reaction (acute hemolytic transfusion reaction). - Bacterial contamination: Transfusing blood products contaminated with bacteria — causing sepsis. [Link to: /medical-malpractice/sepsis-malpractice] - Viral contamination: Transfusing blood products contaminated with HIV, hepatitis B, hepatitis C, or other viruses — though modern screening has made this rare. - Transfusion-related acute lung injury (TRALI): A serious immune reaction that causes lung injury and respiratory failure. - Transfusion-associated circulatory overload (TACO): Fluid overload from too much blood — causing heart failure and pulmonary edema. - Allergic reactions: Including anaphylaxis — a severe, life-threatening allergic reaction. - Febrile non-hemolytic reactions: Fever and chills — usually mild but can indicate a more serious problem. - Graft-versus-host disease (GVHD): A rare but usually fatal complication where transfused white blood cells attack the patient's tissues.

Types of Blood Transfusion Errors

Blood transfusion errors can occur at multiple points in the transfusion process:

• Wrong blood type (ABO incompatibility): The most dangerous error. Transfusing ABO-incompatible blood triggers an acute hemolytic reaction — the patient's immune system attacks the transfused blood, causing fever, chills, back pain, kidney failure, shock, and potentially death.
• Patient misidentification: Transfusing the wrong patient — due to failure to properly identify the patient before transfusion (e.g., not checking wristbands or using two patient identifiers). [Link to: /medication-errors/wrong-drug-interaction]
• Labeling errors: Mislabeling blood samples or blood products — leading to wrong-type transfusions.
• Cross-matching errors: Errors in the blood bank's cross-matching process — failing to detect incompatibility between donor and recipient blood.
• Storage errors: Improper storage (temperature, duration) — compromising the blood product's safety and effectiveness.
• Administration errors: Improper administration — including wrong rate, wrong route, or failure to monitor for reactions.
• Failure to obtain informed consent: Not adequately explaining the risks of transfusion — including the risk of infection, immune reactions, and other complications. [Link to: /surgical-errors/informed-consent]
• Failure to monitor: Not monitoring the patient during and after transfusion — delaying recognition of transfusion reactions.
• Contaminated blood products: Transfusing blood products contaminated with bacteria, viruses, or other pathogens.
• Improper irradiation: Failure to irradiate blood products for immunocompromised patients — increasing the risk of GVHD.

ABO-Incompatible Transfusions: The Most Dangerous Error

An ABO-incompatible transfusion occurs when a patient receives blood of the wrong ABO type. This is the most dangerous transfusion error — and is almost always preventable.

How it happens: The error typically occurs due to: - Patient misidentification: Not properly identifying the patient before drawing blood for typing or before administering the transfusion. - Sample mix-up: The blood sample sent to the blood bank is from the wrong patient. - Labeling error: The blood sample or blood product is mislabeled. - Cross-match error: The blood bank fails to detect incompatibility. - Administration error: The wrong blood product is given to the wrong patient.

What happens: When ABO-incompatible blood is transfused, the patient's immune system immediately attacks the transfused red blood cells — causing: - Acute hemolytic transfusion reaction (AHTR): Fever, chills, back/flank pain, chest pain, shortness of breath, hypotension, kidney failure, disseminated intravascular coagulation (DIC), and potentially death. - Intravascular hemolysis: The transfused red blood cells are destroyed inside the blood vessels — releasing hemoglobin that damages the kidneys. - Shock: The reaction can progress to shock and multi-organ failure. - Death: ABO-incompatible transfusions have a mortality rate of approximately 10-20%.

The standard of care requires a "two-check" system — two healthcare providers independently verifying the patient identity, blood product, and compatibility before administration. When this check is not performed — or is performed improperly — ABO-incompatible transfusions can occur.

Transfusion-Related Acute Lung Injury (TRALI)

Transfusion-related acute lung injury (TRALI) is a serious immune reaction that causes lung injury and respiratory failure — and is the leading cause of transfusion-related mortality.

TRALI occurs when antibodies in the donor's plasma attack the recipient's white blood cells — causing them to aggregate in the lungs and cause inflammation and fluid accumulation (non-cardiogenic pulmonary edema).

Symptoms: Dyspnea (shortness of breath), hypoxia (low oxygen), fever, hypotension, and bilateral pulmonary infiltrates (seen on chest X-ray) — developing during or within 6 hours of transfusion.

TRALI can be life-threatening — requiring mechanical ventilation and intensive care support. While TRALI is not always preventable (as it depends on donor antibodies), the standard of care requires: - Recognition of TRALI symptoms during and after transfusion - Immediate cessation of the transfusion - Prompt respiratory support (oxygen, mechanical ventilation) - Reporting the reaction to the blood bank - Avoiding future transfusions from the same donor

Failure to recognize and treat TRALI promptly can be malpractice. [Link to: /medical-malpractice/icu-negligence]

Transfusion-Associated Circulatory Overload (TACO)

Transfusion-associated circulatory overload (TACO) occurs when a patient receives too much blood or receives it too quickly — causing fluid overload, heart failure, and pulmonary edema.

TACO is particularly dangerous for: - Elderly patients — who have reduced cardiac reserve. - Patients with heart or kidney disease — who cannot handle additional fluid. - Pediatric patients — particularly infants with low blood volume. - Patients receiving large-volume transfusions — such as massive transfusion for trauma or surgery.

Symptoms: Dyspnea, hypertension, tachycardia, widened pulse pressure, pulmonary edema (fluid in the lungs), and elevated jugular venous pressure.

The standard of care requires: - Assessing the patient's cardiac and renal status before transfusion - Calculating the appropriate volume for the patient's size and condition - Administering at the appropriate rate — slower for high-risk patients - Monitoring for signs of overload — including vital signs, oxygen saturation, and respiratory status - Using diuretics (e.g., furosemide) if fluid overload occurs

Failure to assess risk, administer at the appropriate rate, or monitor for overload can cause TACO — and may constitute malpractice.

Transfusion-Transmitted Infections

While modern blood screening has made transfusion-transmitted infections rare, they can still occur:

- Bacterial contamination: The most common transfusion-transmitted infection — particularly in platelet transfusions (which are stored at room temperature, allowing bacterial growth). Bacterial contamination can cause sepsis and death. [Link to: /medical-malpractice/sepsis-malpractice] - HIV: Modern screening (nucleic acid testing) has reduced the risk to approximately 1 in 2 million transfusions — but it is not zero. - Hepatitis B and C: The risk is very low with modern screening — but not zero. - Other pathogens: Including West Nile virus, Zika virus, and emerging pathogens.

The standard of care for blood banks includes: - Donor screening: Screening donors for risk factors and testing for infectious diseases. - Nucleic acid testing (NAT): Testing for HIV, hepatitis B, hepatitis C, West Nile virus, and other pathogens. - Bacterial detection: Testing platelet products for bacterial contamination. - Proper storage: Storing blood products at the appropriate temperature to prevent bacterial growth. - Pathogen reduction: Using pathogen reduction technologies for platelets and plasma.

When a blood bank fails to follow these standards — and a patient is infected — it may constitute malpractice.

The Standard of Care for Blood Transfusions

The standard of care for blood transfusions is established by the AABB (formerly the American Association of Blood Banks), the American Red Cross, the FDA, and The Joint Commission. Key elements include:

1. Proper indication: Transfusing only when clinically indicated — not unnecessarily.

2. Informed consent: Explaining the risks, benefits, and alternatives of transfusion — including the risk of immune reactions, infections, and other complications. [Link to: /surgical-errors/informed-consent]

3. Patient identification: Using two patient identifiers (name and date of birth) — and checking the wristband — before drawing blood for typing and before administering transfusion.

4. Proper blood typing and cross-matching: Performing ABO/Rh typing and cross-matching in the blood bank — to detect incompatibility.

5. Two-check system: Two healthcare providers independently verifying the patient identity, blood product, and compatibility before administration.

6. Proper storage: Storing blood products at the appropriate temperature and for the appropriate duration.

7. Appropriate administration rate: Administering at the appropriate rate — slower for high-risk patients (elderly, cardiac/renal disease).

8. Monitoring: Monitoring vital signs, oxygen saturation, and patient status during and after transfusion — and recognizing transfusion reactions promptly.

9. Prompt response to reactions: Stopping the transfusion immediately if a reaction occurs — and providing appropriate treatment (IV fluids, antihistamines, steroids, epinephrine for anaphylaxis, diuretics for TACO, respiratory support for TRALI).

10. Documentation: Documenting the transfusion — including the blood product, volume, rate, patient response, and any reactions.

Proving Causation in Transfusion Error Cases

Proving that a blood transfusion error caused harm requires establishing:

1. The standard of care was breached: Expert testimony from a hematologist, blood bank specialist, or transfusion medicine expert — that the provider failed to properly identify the patient, match the blood type, store the blood product, administer at the appropriate rate, or monitor for reactions.

2. The breach caused the harm: Expert testimony linking the specific error to the patient's harm — whether an ABO-incompatible transfusion reaction, TRALI, TACO, infection, or other complication.

3. The patient suffered damages: Including medical expenses, lost wages, pain and suffering, organ damage, or death.

The defense may argue that the complication was a known risk of transfusion, that the patient had underlying conditions, or that the outcome was inevitable. Expert testimony is required to counter these arguments — and to show that the standard of care was breached and that the breach caused the harm.

New York Statute of Limitations

Under CPLR § 214-a, the statute of limitations for blood transfusion malpractice is 2.5 years from the date of the negligent transfusion. The continuous treatment doctrine may extend the deadline if you continued receiving treatment from the same provider for complications of the transfusion. For transfusion-transmitted infections (HIV, hepatitis), the discovery rule may apply — starting the clock when the infection was discovered. For wrongful death (if the patient died), the deadline is 2 years from the date of death (EPTL § 5-4.1). [Link to: /medication-errors/statute-of-limitations] [Link to: /wrongful-death/statute-of-limitations]

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.